Drug Resistance Updates
Volume 12, Issue 4 , Pages 95-102 , August 2009

The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer

  • Scott A. Kono

      Affiliations

    • Department of Medicine, University of Colorado at Denver Anschutz Medical Campus, Aurora, CO 80045, United States
  • ,
  • Marianne E. Marshall

      Affiliations

    • Department of Craniofacial Biology, University of Colorado at Denver Anschutz Medical Campus, Aurora, CO 80045, United States
  • ,
  • Kathryn E. Ware

      Affiliations

    • Department of Craniofacial Biology, University of Colorado at Denver Anschutz Medical Campus, Aurora, CO 80045, United States
  • ,
  • Lynn E. Heasley

      Affiliations

    • Department of Craniofacial Biology, University of Colorado at Denver Anschutz Medical Campus, Aurora, CO 80045, United States
    • Corresponding Author InformationCorresponding author at: Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Denver Anschutz Medical Campus, Mail Stop 8120, P.O. Box 6511, Aurora, CO 80045, United States. Fax: +1 303 724 4580.

Received 15 April 2009 ,Revised 9 May 2009 ,Accepted 11 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1368-7646(09)00028-4

doi: 10.1016/j.drup.2009.05.001

Drug Resistance Updates
Volume 12, Issue 4 , Pages 95-102 , August 2009